http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14034858

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 2162
issn 0008-543X
1097-0142
issueIdentifier 10
pageRange 2156-2162
publicationName Cancer
startingPage 2156
bibliographicCitation Tiribelli M, Geromin A, Michelutti A, Cavallin M, Pianta A, Fabbro D, Russo D, Damante G, Fanin R, Damiani D. Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse. Cancer. 2011 May 15;117(10):2156–62. doi: 10.1002/cncr.25753. PMID: 21523728.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc0e5283a00180b6a964913d85369cf9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2312-4009
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8854096e9deee9afeefe52dc9a171d41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a347852fe3300e1d48e4f7b3d6a05a1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_146d7f56b6783ad91a01776e463a67a6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_813dbaf1a5ec4618221828251af453a0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9449-2621
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b3bd76c919cf4829f09da6509061f06
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19553ceb4eb825fc1c37f0d7dd99df9e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1663-4468
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_565e5b3691fabab2c94a3e36c1ed3ac6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df8dc03a4e7052bb2560c4c7534ef7ed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cd9d57b691fe68361d595a37d326faf
date 2010-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/21523728
https://doi.org/10.1002/cncr.25753
isPartOf https://portal.issn.org/resource/ISSN/0008-543X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771
https://portal.issn.org/resource/ISSN/1097-0142
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Concomitant ABCG2 overexpression and FLT3‐ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse
discusses http://id.nlm.nih.gov/mesh/M000612844
http://id.nlm.nih.gov/mesh/M0014578
http://id.nlm.nih.gov/mesh/M0022659
http://id.nlm.nih.gov/mesh/M0027776
http://id.nlm.nih.gov/mesh/M0299734
http://id.nlm.nih.gov/mesh/M0468902
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0190176
http://id.nlm.nih.gov/mesh/M0082555
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D018528Q000235
http://id.nlm.nih.gov/mesh/D020080
http://id.nlm.nih.gov/mesh/D009363Q000235
http://id.nlm.nih.gov/mesh/D015470Q000235
http://id.nlm.nih.gov/mesh/D051941Q000235
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014740Q000031
http://id.nlm.nih.gov/mesh/D014740Q000627
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D012074
http://id.nlm.nih.gov/mesh/D051941Q000378
http://id.nlm.nih.gov/mesh/D000070997
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D015470Q000188
http://id.nlm.nih.gov/mesh/D009154
http://id.nlm.nih.gov/mesh/D012008
http://id.nlm.nih.gov/mesh/D009363Q000378
http://id.nlm.nih.gov/mesh/D018528Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657237
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45bd205c63f9c9cfc7d5ba167cb355f0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1e4d7f806ea44eba476b32d2ebb4249

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127960150
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2322
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814614

Total number of triples: 74.